These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28881648)

  • 1. Correlation between microRNA-143 in peripheral blood mononuclear cells and disease severity in patients with psoriasis vulgaris.
    Zheng YZ; Chen CF; Jia LY; Yu TG; Sun J; Wang XY
    Oncotarget; 2017 Aug; 8(31):51288-51295. PubMed ID: 28881648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis.
    Løvendorf MB; Zibert JR; Gyldenløve M; Røpke MA; Skov L
    J Dermatol Sci; 2014 Aug; 75(2):133-9. PubMed ID: 24909097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-146a and miR-99a are potential biomarkers for disease activity and clinical efficacy assessment in psoriasis patients treated with traditional Chinese medicine.
    Yang Z; Zeng B; Tang X; Wang H; Wang C; Yan Z; Huang P; Pan Y; Xu B
    J Ethnopharmacol; 2016 Dec; 194():727-732. PubMed ID: 27562321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity.
    García-Rodríguez S; Arias-Santiago S; Blasco-Morente G; Orgaz-Molina J; Rosal-Vela A; Navarro P; Magro-Checa C; Martínez-López A; Ruiz JC; Raya E; Naranjo-Sintes R; Sancho J; Zubiaur M
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):312-322. PubMed ID: 27535005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of death receptor 3 (DR3) on peripheral blood mononuclear cells of patients with psoriasis vulgaris.
    Li L; Lu Y; Fu L; Zhou P; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Zhou Y; Chen T
    Postgrad Med J; 2018 Oct; 94(1116):551-555. PubMed ID: 30341229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased MicroRNA-1266 levels as a biomarker for disease activity in psoriasis vulgaris.
    Seifeldin NS; El Sayed SB; Asaad MK
    Int J Dermatol; 2016 Nov; 55(11):1242-1247. PubMed ID: 27371164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on different expressions of peripheral blood Th1/Th2 cells in psoriasis patients of blood heat syndrome and of blood stasis syndrome].
    Chen J; Cao XX; Xu R; Li X; Li FL; Fan B; Wang YF; Li F; Li B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):46-50. PubMed ID: 24520787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris.
    Zhang P; Su Y; Zhao M; Huang W; Lu Q
    Eur J Dermatol; 2011; 21(4):552-7. PubMed ID: 21715244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity.
    Lu J; Ding Y; Yi X; Zheng J
    Braz J Med Biol Res; 2016 Aug; 49(9):e5374. PubMed ID: 27532281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris.
    Zhu K; Ye J; Wu M; Cheng H
    Arch Dermatol Res; 2010 Sep; 302(7):517-23. PubMed ID: 20333526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris.
    Yamamoto T; Katayama I; Nishioka K
    Eur J Dermatol; 1998; 8(5):325-9. PubMed ID: 9683864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris.
    Sehat M; Talaei R; Dadgostar E; Nikoueinejad H; Akbari H
    Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):179-187. PubMed ID: 29757591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W; Kang XL; Cen S; Wang Y; Chen X
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic significance of PGGT1B in psoriasis.
    Hao Z; Lian N; Gu H; Chen M
    Dermatol Ther; 2021 Mar; 34(2):e14854. PubMed ID: 33548109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-3934 in Peripheral Blood Mononuclear Cells of Asthmatic Patients and Its Potential Diagnostic Value.
    Wang W; Wang J; Chen H; Zhang X; Han K
    Biomed Res Int; 2021; 2021():8888280. PubMed ID: 33506046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity.
    Guo S; Zhang W; Wei C; Wang L; Zhu G; Shi Q; Li S; Ge R; Li K; Gao L; Gao T; Wang G; Li C
    Eur J Dermatol; 2013; 23(5):608-13. PubMed ID: 24135466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production.
    Mazloom H; Alizadeh S; Pasalar P; Esfahani EN; Meshkani R
    Cytokine; 2015 Dec; 76(2):403-408. PubMed ID: 26188366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
    Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
    He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
    Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum IL-30 and soluble GP130 with the risk of psoriasis vulgaris.
    Shehata RR; Atta SA; Fatma AS; Aml RA; Gomaa AS
    Egypt J Immunol; 2024 Apr; 31(2):61-70. PubMed ID: 38615236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.